172 related articles for article (PubMed ID: 35779876)
1. Chemobrain: A review on mechanistic insight, targets and treatments.
Rao V; Bhushan R; Kumari P; Cheruku SP; Ravichandiran V; Kumar N
Adv Cancer Res; 2022; 155():29-76. PubMed ID: 35779876
[TBL] [Abstract][Full Text] [Related]
2. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity.
Shi DD; Huang YH; Lai CSW; Dong CM; Ho LC; Li XY; Wu EX; Li Q; Wang XM; Chen YJ; Chung SK; Zhang ZJ
Mol Neurobiol; 2019 Aug; 56(8):5626-5642. PubMed ID: 30659419
[TBL] [Abstract][Full Text] [Related]
4. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
5. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
6. Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions.
Skurlova M; Holubova K; Kleteckova L; Kozak T; Kubova H; Horacek J; Vales K
Med Res Rev; 2024 Jan; 44(1):5-22. PubMed ID: 37265248
[TBL] [Abstract][Full Text] [Related]
7. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Sahu K; Singh S; Devi B; Singh C; Singh A
Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
[TBL] [Abstract][Full Text] [Related]
8. Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward.
Raghu SV; Kudva AK; Rao S; Prasad K; Mudgal J; Baliga MS
Food Funct; 2021 Nov; 12(22):11132-11153. PubMed ID: 34704580
[TBL] [Abstract][Full Text] [Related]
9. Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration.
Cardoso CV; de Barros MP; Bachi ALL; Bernardi MM; Kirsten TB; de Fátima Monteiro Martins M; Rocha PRD; da Silva Rodrigues P; Bondan EF
Behav Brain Res; 2020 Jan; 378():112233. PubMed ID: 31521736
[TBL] [Abstract][Full Text] [Related]
10. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.
Orchard TS; Gaudier-Diaz MM; Weinhold KR; Courtney DeVries A
Breast Cancer Res Treat; 2017 Feb; 161(3):391-398. PubMed ID: 27933449
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
Alhowail AH; Aldubayan M
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation.
Ali MA; Menze ET; Tadros MG; Tolba MF
Neuropharmacology; 2020 Dec; 181():108334. PubMed ID: 33011199
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.
Rummel NG; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Cell Mol Life Sci; 2021 Oct; 78(19-20):6533-6540. PubMed ID: 34424346
[TBL] [Abstract][Full Text] [Related]
14. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
[No Abstract] [Full Text] [Related]
15. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
Guran E; Hu J; Wefel JS; Chung C; Cata JP
Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
17. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
Nguyen LD; Ehrlich BE
EMBO Mol Med; 2020 Jun; 12(6):e12075. PubMed ID: 32346964
[TBL] [Abstract][Full Text] [Related]
19. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
20. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.
Wang XM; Walitt B; Saligan L; Tiwari AF; Cheung CW; Zhang ZJ
Cytokine; 2015 Mar; 72(1):86-96. PubMed ID: 25573802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]